Investor Relations We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology. Email Alerts Investors: Overview Press Releases Events and Presentations Financials & Filings Stock Information Investor FAQs Contact Us Investor Alerts RSS Investor Alerts * Required Fields (Click here to unsubscribe) All AlertsCustomize Alerts Articles All Events and Webcasts Financial Conferences Results Announcements Stockholder Meetings Webcasts Daily Closing Stock Price Stock Price: End of Week Summary All SEC Filings Annual Filings Quarterly Filings Current Filings Registration Statements Section 16 Mergers & Acquisitions Proxy & Information Statements Other News Releases Quarterly Results First Name Last Name * Email Company Phone